1.
Cao M, Lin Q, Lin L, Zhang W, Zhang L. The Efficacy and Safety of Empagliflozin in Elderly Patients with Type 2 Diabetes Mellitus Complicating Cardiorenal Syndromes Type II and IV: Evaluation of Empagliflozin in CRS. J Med Biochem [Internet]. 2025 Apr. 28 [cited 2026 Jul. 12];44(4):905-14. Available from: https://asistent.ceon.rs/index.php/jomb/article/view/54743